Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of propolis on the treatment of oral candidiasis, more specifically denture stomatitis. Half of participants will receive a standardized-propolis (EPP-AF®) gel formulation while the other half will receive miconazole gel, both for oral use.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02818803
Study type Interventional
Source University of Sao Paulo
Contact
Status Completed
Phase Phase 3
Start date January 2016
Completion date June 2016

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03250923 - CelAgaceā„¢ OraRinse Solution for Treatment of Candidiasis Phase 1/Phase 2
Completed NCT00004781 - Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups N/A
Completed NCT03894839 - Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species N/A
Completed NCT00128323 - A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Phase 3
Recruiting NCT04410250 - Effect of Oral Hygienization in Newborn on Candida Spp Colonization N/A
Completed NCT02184351 - Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis Phase 3
Recruiting NCT03873753 - Relationship Between Oral Hygiene in Newborns and Candida Spp. N/A
Completed NCT00665639 - Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis Phase 3
Recruiting NCT06120816 - Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis Phase 1
Completed NCT00235053 - Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID Phase 4
Completed NCT00666185 - Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis Phase 3
Completed NCT00002446 - Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Phase 3
Completed NCT00001448 - The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection N/A
Completed NCT00612963 - Novel Rinse to Treat in Oral Candidiasis in Cancer Patients N/A
Completed NCT00001812 - A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Phase 3
Completed NCT00002282 - A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS N/A
Terminated NCT00005920 - Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole Phase 2
Completed NCT00002293 - A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes N/A
Completed NCT00002112 - Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome N/A
Completed NCT00002431 - The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients N/A